Collection
COVID-19
The ongoing global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused hundreds of millions of infections, and millions of deaths have been attributed to the disease. Publishing research on Covid-19 is crucial to understand how it affects patients, to combat the disease, and to ultimately overcome this global health emergency.
The Journal of Neurology has dedicated an article collection to neurological research in connection to Covid-19. This article collection aims to gather all articles relevant to neurological disease and Covid-19 in one place, so that researchers and clinicians can easily access reviews, original articles, short commentaries and case reports on the subject.
The article collection on Covid-19 will remain open; manuscripts on Covid-19 can be submitted freely to the journal and will be added to the collection upon publication. Submissions on Covid-19 are subject to the rigorous peer review the journal conducts for all unsolicited manuscripts. Peer review of Covid-19 manuscripts is steered by Massimo Filippi, one of the Chief Editors of Journal of Neurology. A related collection in the journal features articles on Long COVID-19 Syndrome.
Editors
-
Massimo Filippi
Massimo Filippi is Full Professor of Neurology at Università Vita-Salute San Raffaele, Milan, Italy; Director Residency School in Neurology; Chair of the Neurology Unit, Neurorehabilitation Unit and Neurophysiology Service and Director of the Neuroimaging Research Unit, Department of Neurology, IRCCS Ospedale San Raffaele, Milan. His research focuses on the definition of the mechanisms leading to progressive accumulation of irreversible physical disability and cognitive impairment in various neurological conditions. He is Chief Editor of the Journal of Neurology and responsible for the article collection on Covid-19.
Articles (206 in this collection)
-
-
-
Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events
Authors (first, second and last of 9)
-
Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature
Authors (first, second and last of 12)
-
A rise in cases of nitrous oxide abuse: neurological complications and biological findings
Authors (first, second and last of 12)
-
COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration?
Authors (first, second and last of 15)
-
Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience
Authors (first, second and last of 6)
-
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex
Authors (first, second and last of 5)
-
Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2
Authors (first, second and last of 6)
-
Global survey on disruption and mitigation of neurological services during COVID-19: the perspective of global international neurological patients and scientific associations
Authors (first, second and last of 15)
-
-
Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study
Authors (first, second and last of 8)
-
Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report
Authors (first, second and last of 4)
-
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy
Authors (first, second and last of 49)
-
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis
Authors (first, second and last of 6)
-
Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review
Authors (first, second and last of 9)
-
COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2
Authors (first, second and last of 11)
-
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung
Authors (first, second and last of 8)
-
Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome
Authors (first, second and last of 8)
-
Navigating migraine care through the COVID-19 pandemic: an update
Authors (first, second and last of 4)
-
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
Authors (first, second and last of 13)
-
The impact of Coronavirus disease 2019 (COVID‐19) pandemic on migraine disorder
Authors (first, second and last of 5)
-
Neurological and cognitive sequelae of Covid-19: a four month follow-up
Authors (first, second and last of 6)
-
-
Intraluminal carotid thrombosis and acute ischemic stroke associated with COVID-19
Authors (first, second and last of 6)
-
-
-
Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19
Authors (first, second and last of 11)
-
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients
Authors (first, second and last of 9)
-
-
-
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?
Authors (first, second and last of 7)
-
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
Authors (first, second and last of 10)
-
Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19
Authors (first, second and last of 4)
-
Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection
Authors (first, second and last of 5)
-
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
Authors (first, second and last of 15)
-
Brainstem clinical and neurophysiological involvement in COVID-19
Authors (first, second and last of 7)
-
Could symptom overlap of COVID-19 and Guillain–Barré syndrome mask an epidemiological association?
Authors (first, second and last of 4)
-
-
Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients
Authors (first, second and last of 7)
-
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network
Authors (first, second and last of 49)
-
Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
Authors (first, second and last of 5)
-
Hospital admissions of acute cerebrovascular diseases during and after the first wave of the COVID-19 pandemic: a state-wide experience from Austria
Authors (first, second and last of 9)
-
Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review
Authors (first, second and last of 24)
-
Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review
Authors
-
-
COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
Authors (first, second and last of 4)
-
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
Authors (first, second and last of 13)
-
COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy
Authors (first, second and last of 6)
-
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data
Authors (first, second and last of 5)
